Record NNP B-NP O
date NN I-NP O
: : O O
2091-12-12 CD O B-DATE
Team NNP B-NP O
B NNP I-NP O
Intern NNP I-NP O
Admission NNP I-NP O
Note NN I-NP O
Name VB B-VP O
: : O O
French NNP B-NP I-PATIENT
, , O I-PATIENT
Xue NNP B-NP I-PATIENT
MRN NNP B-NP O
: : O O
875-10-45 CD O B-MEDICALRECORD
Date NNP B-NP O
of IN B-PP O
Admission NNP B-NP O
: : O O
12-Dec-2091 CD O B-DATE
PCP NNP B-NP O
: : O O
Dr. NNP B-NP O
John NNP I-NP B-DOCTOR
Hood NNP I-NP I-DOCTOR
( -LRB- I-NP O
Resident NN I-NP O
- : O O
PVH NNS B-VP B-HOSPITAL
Isabela NNP B-NP B-CITY
Healthcare NNP I-NP O
Center NNP I-NP O
) -RRB- O O
Other JJ B-NP O
PVH NNP I-NP B-HOSPITAL
providers NNS I-NP O
: : O O
Dr. NNP B-NP O
Raymond NNP I-NP B-DOCTOR
Xie NNP I-NP I-DOCTOR
- : O O
Rheum NN B-NP O
Admitting NNP B-NP O
Intern NNP I-NP O
: : O O
Olivia NNP B-NP B-DOCTOR
H. NNP I-NP I-DOCTOR
Grant NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
Team NN B-NP O
: : O O
B NNP O O
CC NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
a DT B-NP O
59 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
female NN I-NP O
with IN B-PP O
h/o NN B-NP O
SLE NNP I-NP O
, , I-NP O
interstitial JJ I-NP O
nephritis NN I-NP O
, , O O
GERD NNP B-NP O
, , O O
h/o RB B-NP O
positive JJ I-NP O
stress NN I-NP O
s/p VBD B-VP O
RCA NNP B-NP O
angioplasty JJ I-NP O
2082 CD I-NP B-DATE
, , O O
and CC O O
chronic NN B-NP O
abdominal JJ I-NP O
pain NN I-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
c/o JJ B-NP O
two CD I-NP O
weeks NNS I-NP O
of IN B-PP O
intermittent NN B-NP O
chest NN I-NP O
pain NN I-NP O
. . O O
HPI NNP B-NP O
: : O O
Pt NNP B-NP O
initially RB B-ADVP O
presented VBD B-VP O
to TO B-PP O
her PRP$ B-NP O
PCP NNS I-NP O
on IN B-PP O
day NN B-NP O
of IN B-PP O
admission NN B-NP O
with IN B-PP O
a DT B-NP O
complaint NN I-NP O
of IN B-PP O
2 CD B-NP O
weeks NNS I-NP O
of IN B-PP O
intermittent NN B-NP O
chest NN I-NP O
pain NN I-NP O
. . O O
Pt NNP B-NP O
reported VBD B-VP O
that IN B-SBAR O
pain NN B-NP O
has VBZ B-VP O
been VBN I-VP O
lasting VBG I-VP O
anywhere RB B-ADVP O
from IN B-PP O
20 CD B-NP O
min NN I-NP O
to TO B-PP O
1 CD B-NP O
hour NN I-NP O
and CC O O
that IN B-SBAR O
it PRP B-NP O
emanates VBZ B-VP O
from IN B-PP O
the DT B-NP O
L NNP I-NP O
sternal JJ I-NP O
border NN I-NP O
with IN B-PP O
radiation NN B-NP O
to TO B-PP O
L NNP B-NP O
lateral JJ I-NP O
thorax NN I-NP O
and CC I-NP O
radiation NN I-NP O
to TO B-PP O
L NNP B-NP O
arm NN I-NP O
, , O O
accompanied VBN B-VP O
by IN B-PP O
tingling/numbness NN B-NP O
in IN B-PP O
L NNP B-NP O
digits NNS I-NP O
+ VBP B-VP O
occasionally RB B-ADVP O
right JJ B-NP O
digits NNS I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
down IN B-PP O
the DT B-NP O
L NNP I-NP O
leg NN I-NP O
. . O O
In IN B-PP O
PVH NNP B-NP B-HOSPITAL
ED NNP I-NP O
, , O O
pt NN B-NP O
describes VBZ B-VP O
the DT B-NP O
pain NN I-NP O
as IN B-PP O
like IN B-PP O
a DT B-NP O
bleeding VBG I-NP O
scar NN I-NP O
and CC O O
states VBZ B-VP O
my PRP$ B-NP O
heart NN I-NP O
is VBZ B-VP O
bloated VBN I-VP O
through IN B-PP O
her PRP$ B-NP O
daughter NN I-NP O
who WP B-NP O
acted VBD B-VP O
as IN B-PP O
her PRP$ B-NP O
interpreter NN I-NP O
. . O O
She PRP B-NP O
reports VBZ B-VP O
that IN B-SBAR O
the DT B-NP O
pain NN I-NP O
, , O O
at IN B-SBAR O
it PRP B-NP O
's VBZ B-VP O
worst JJS B-ADJP O
is VBZ B-VP O
5/10 CD B-NP O
, , O O
but CC O O
has VBZ B-VP O
improved VBN I-VP O
to TO B-PP O
2/10 CD B-NP O
after IN B-PP O
NTG NNP B-NP O
en IN B-SBAR O
route NN B-NP O
to TO B-PP O
the DT B-NP O
ED NNP I-NP O
and CC O O
once RB B-ADVP O
in IN B-PP O
the DT B-NP O
ED. NNP I-NP O
She PRP B-NP O
affirms VBZ B-VP O
nausea NN B-NP O
and CC I-NP O
diaphoresis NN I-NP O
accompany VB B-VP O
pain NN B-NP O
. . O O
Pain NNP B-NP O
has VBZ B-VP O
no DT B-NP O
relationship NN I-NP O
to TO B-VP O
position VB I-VP O
or CC I-VP O
activity NN I-VP O
-- : O O
has VBZ B-VP O
occurred VBN I-VP O
during IN B-PP O
sitting VBG B-NP O
, , I-NP O
ambulation NN I-NP O
, , O O
and CC O O
reclining VBG B-VP O
. . B-NP O
Pt NNP I-NP O
lives VBZ B-VP O
on IN B-PP O
the DT B-NP O
second JJ I-NP O
story NN I-NP O
of IN B-PP O
her PRP$ B-NP O
building NN I-NP O
and CC O O
has VBZ B-VP O
noted VBN I-VP O
that IN B-PP O
walking VBG B-VP O
up IN B-PRT O
stairs NNS B-NP O
has VBZ B-VP O
been VBN I-VP O
been VBN I-VP O
more RBR B-ADJP O
difficult JJ I-ADJP O
over IN B-SBAR O
the DT B-NP O
past JJ I-NP O
two CD I-NP O
weeks NNS I-NP O
secondary JJ B-ADJP O
to TO B-PP O
calf NN B-NP O
and CC I-NP O
ankle NN I-NP O
pain NN I-NP O
, , O O
L NNP B-NP O
> NNP I-NP O
R, NNP I-NP O
follow VBP B-VP O
by IN B-PP O
chest NN B-NP O
pain NN I-NP O
. . O O
Pt NNP B-NP O
has VBZ B-VP O
not RB I-VP O
had VBD I-VP O
to TO I-VP O
use VB I-VP O
more JJR B-NP O
pillows NNS I-NP O
in IN B-PP O
the DT B-NP O
past JJ I-NP O
two CD I-NP O
weeks NNS I-NP O
when WRB B-ADVP O
sleeping VBG B-NP O
, , O O
and CC O O
reports VBZ B-VP O
no DT B-NP O
change NN I-NP O
in IN B-PP O
the DT B-NP O
number NN I-NP O
of IN B-PP O
times NNS B-NP O
per IN B-PP O
week NN B-NP O
that IN B-SBAR O
she PRP B-NP O
wakes VBZ B-VP O
up RP B-ADJP O
short JJ I-ADJP O
of IN B-PP O
breath NN B-NP O
, , O O
which WDT B-NP O
varies VBZ B-VP O
between IN B-PP O
one CD B-NP O
to TO I-NP O
two CD I-NP O
times NNS I-NP O
per IN B-PP O
week NN B-NP O
. . O O
Pt NNP B-NP O
denies VBZ B-VP O
increased VBN I-VP O
swelling VBG I-VP O
in IN B-PP O
extremities NNS B-NP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
two CD I-NP O
weeks NNS I-NP O
or CC I-NP O
increase NN I-NP O
in IN B-PP O
weight NN B-NP O
. . O O
Allergies . O O
* VB B-NP O
Celebrex NNP I-NP O
- : O O
SOB NN B-VP O
: : O O
" `` O O
that IN B-NP O
triggered VBD B-VP O
her PRP$ B-NP O
asthma NN I-NP O
" '' O O
Medications NNS B-NP O
Aspirin NNP B-NP O
(ACETYLSALICYLIC NN I-NP O
Acid NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Calcium NNP B-NP O
Gluconate NNP I-NP O
500MG NNP I-NP O
, , O O
2 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
x1 . O O
Vitamin NN B-NP O
D NNP I-NP O
( -LRB- I-NP O
ERGOCALCIFEROL NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD . O O
Nitroglycerin NNP B-NP O
1/150 CD I-NP O
( -LRB- I-NP O
0.4 CD I-NP O
Mg NN I-NP O
) -RRB- O O
1 CD B-NP O
TAB NNP I-NP O
SL NNP I-NP O
: : O O
PRN NN B-NP O
Vioxx NNP B-NP O
( -LRB- I-NP O
ROFECOXIB NNP I-NP O
) -RRB- I-NP O
25MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD NNP I-NP O
PRN NNP I-NP O
leg NN I-NP O
pain NN I-NP O
Nifedipine NNP B-NP O
( -LRB- I-NP O
EXTENDED NNP I-NP O
Release NNP I-NP O
) -RRB- I-NP O
90MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
HYDROXYCHLOROQUINE NNP B-NP O
200MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
ATENOLOL NNP B-NP O
50MG JJ I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Protonix NNP B-NP O
( -LRB- I-NP O
PANTOPRAZOLE NN I-NP O
) -RRB- I-NP O
40MG CD I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
PREDNISONE JJ B-NP O
10MG JJ I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
x NN I-NP O
30 CD B-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Isosorbide NNP B-NP O
Dinitrate NNP I-NP O
30MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Social NNP B-NP O
History NNP I-NP O
Pt NNP B-NP O
originally RB B-ADVP O
from IN B-PP O
Hawley NNP B-NP B-CITY
, , O O
Puerto NNP B-NP B-COUNTRY
Rico NNP I-NP I-COUNTRY
. . O O
She PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
married VBN I-VP O
for IN B-PP O
23 CD B-NP O
yrs NNS I-NP O
and CC O O
currently RB B-VP O
lives VBZ I-VP O
with IN B-PP O
her PRP$ B-NP O
husband NN I-NP O
and CC O O
one CD B-NP O
grandson NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
4 CD B-NP O
children NNS I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
G4P4 NNP B-NP O
. . I-NP O
LIfetime NNP I-NP O
non-smoker NN I-NP O
. . O O
No DT B-NP O
alcohol NN I-NP O
or CC I-NP O
drugs NNS I-NP O
. . O O
She PRP B-NP O
does VBZ B-VP O
not RB I-VP O
work VB I-VP O
anymore RB B-ADVP O
but CC O O
did VBD B-VP O
work VB I-VP O
in IN B-PP O
fire NN B-NP B-PROFESSION
prevention NN I-NP I-PROFESSION
. . O O
Family NNP B-NP O
History NN I-NP O
Father NNP B-NP O
and CC O O
ten CD B-NP O
siblings NNS I-NP O
with IN B-PP O
h/o NN B-NP O
heart NN I-NP O
disease NN I-NP O
but CC O O
pt RB B-ADJP O
uncertain JJ I-ADJP O
as IN B-PP O
to TO B-PP O
the DT B-NP O
age NN I-NP O
of IN B-PP O
onset NN B-NP O
or CC I-NP O
nature NN I-NP O
of IN B-PP O
heart NN B-NP O
disease NN I-NP O
by IN B-PP O
ED JJ B-NP O
report NN I-NP O
. . O O
Review NNP B-NP O
of IN I-NP O
Systems NNPS O O
Constitutional NNP B-NP O
- : O O
no DT B-NP O
involuntary JJ I-NP O
weight NN I-NP O
loss NN I-NP O
, , O O
malaise NN B-NP O
, , O O
or CC O O
anorexia DT B-NP O
. . I-NP O
Pt NNP I-NP O
reports VBZ B-VP O
increased VBN I-VP O
sweating VBG I-VP O
a DT B-NP O
night NN I-NP O
and CC O O
during IN B-PP O
the DT B-NP O
day NN I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
fatigue NN B-NP O
which WDT B-NP O
has VBZ B-VP O
been VBN I-VP O
a DT B-NP O
long JJ I-NP O
standing NN I-NP O
issue NN I-NP O
with IN B-PP O
pt NN B-NP O
. . O O
CV NNP B-NP O
- : O O
chest NN B-VP O
pain NN B-NP O
as IN B-PP O
per IN B-PP O
HPI NNP B-NP O
; : O O
no DT B-NP O
change NN I-NP O
in IN B-PP O
orthopnea NN B-NP O
, , O O
PND NNP B-NP O
, , O O
or CC O O
SOB NNP B-NP O
at IN B-PP O
rest NN B-NP O
. . O O
Pulm NNP B-NP O
- : O O
no DT B-NP O
cough NN I-NP O
, , O O
wheezing VBG B-VP O
, , O O
SOB NNP B-NP O
at IN B-PP O
rest NN B-NP O
. . O O
Abd NNP B-NP O
- : O O
chronic NN B-VP O
abdominal NN B-NP O
pain NN I-NP O
; : O O
no DT B-NP O
BRBPR NN I-NP O
, , O O
melena NN B-NP O
, , O O
constipation NN B-NP O
, , O O
change NN B-NP O
in IN B-PP O
BM. NNP B-NP O
Ext JJ O O
- : O O
no DT B-NP O
LE JJ I-NP O
edema NN I-NP O
MSK NNP B-NP O
- : O O
multiple JJ B-NP O
chronic JJ I-NP O
small JJ I-NP O
jt NN I-NP O
pain NN I-NP O
, , O O
esp VBP B-VP O
PIP. VBG I-VP O
Physical JJ B-NP O
Exam NNP I-NP O
: : O O
Vitals NNS B-NP O
: : O O
T NNP B-NP O
97.6 CD I-NP O
BP NNP I-NP O
140/76 CD I-NP O
HR NNP I-NP O
56 CD I-NP O
RR NNP I-NP O
22 CD I-NP O
Sat NNP I-NP O
99 CD I-NP O
% NN I-NP O
on IN B-PP O
2L NNP B-NP O
of IN B-PP O
O2 NNP B-NP O
via IN B-PP O
NC NNP B-NP O
General NNP B-NP O
: : O O
well RB B-ADVP O
appearing VBG B-VP O
, , O O
cooperative JJ B-ADVP O
, , O O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
Skin NNP B-NP O
: : O O
no DT B-NP O
rashes NNS I-NP O
or CC I-NP O
lesions NNS I-NP O
noted VBN O O
HEENT NNP B-NP O
: : O O
PERRL NN B-NP O
, , O O
MMM NNP B-NP O
, , O O
OP NNP B-NP O
w/o , I-NP O
erythema NN I-NP O
or CC I-NP O
exudates NNS I-NP O
NECK NNP B-NP O
: : O O
Supple NNP B-NP O
, , O O
no DT B-NP O
observable JJ I-NP O
JVD NNP I-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
Respiratory NN B-NP O
: : O O
CTA NNP B-NP O
bilaterally RB B-ADVP O
, , O O
good JJ B-NP O
air NN I-NP O
movmenet NN I-NP O
Chest NNP B-NP O
: : O O
Pain NNP B-NP O
to TO B-PP O
palpation NN B-NP O
at IN B-PP O
L NNP B-NP O
sternal JJ I-NP O
border NN I-NP O
. . O O
CV NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
with IN B-PP O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
S3 NNP I-NP O
, , I-NP O
S4 NNP I-NP O
, , I-NP O
2/6 CD I-NP O
SEM NNP I-NP O
best JJS I-NP O
heard VBN B-VP O
at IN B-PP O
LUSB NNP B-NP O
Abd NNP B-NP O
: : O O
Soft NNP B-VP O
with IN B-PP O
diffuse JJ B-NP O
tenderness NN I-NP O
, , O O
but CC O O
without IN B-PP O
voluntary JJ B-NP O
guarding VBG I-NP O
or CC O O
rebound VB B-VP O
tenderness NN B-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
Extremities NNS B-NP O
: : O O
WWP NNP B-NP O
, , O O
2+ JJ B-NP O
radial JJ I-NP O
, , I-NP O
DP NNP I-NP O
and CC I-NP O
PT NNP I-NP O
pulses NNS I-NP O
, , O O
LLE NNP B-NP O
with IN B-PP O
calf NN B-NP O
and CC I-NP O
shin NN I-NP O
tenderness NN I-NP O
to TO B-PP O
palpation NN B-NP O
. . O O
Labs NNS B-NP O
: : O O
13-Dec-2091 CD B-NP B-DATE
02:11 CD I-NP O
Accession NNP B-NP O
# # I-NP O
8946B57286 CD O B-MEDICALRECORD
WBC NNP B-NP O
7.5 CD I-NP O
( -LRB- O O
4.5-11.0) JJ B-NP O
th/cmm NN I-NP O
HCT NN B-NP O
40.3 CD I-NP O
( -LRB- O O
36.0-46.0) CD B-NP O
% NN I-NP O
HGB NN B-NP O
13.2 CD I-NP O
( -LRB- I-NP O
12.0-16.0) JJ I-NP O
gm/dl NN I-NP O
PLT NNP B-NP O
292 CD I-NP O
( -LRB- I-NP O
150-350 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
13-Dec-2091 CD B-NP B-DATE
02:19 CD I-NP O
Accession NNP B-NP O
# # I-NP O
4894U89067 CD O B-MEDICALRECORD
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Plasma NNP B-NP O
Sodium NNP I-NP O
143 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
3.9 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Chloride NNP I-NP O
106 CD I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
27.7 CD I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Calcium NNP B-NP O
10.0 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus NNP B-NP O
3.7 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP O
1.8 CD I-NP O
( -LRB- O O
1.4-2.0) CD B-NP O
meq/L NN I-NP O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
19 CD I-NP O
(8-25 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
0.9 CD I-NP O
( -LRB- I-NP O
0.6-1.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Protein NNP I-NP O
7.6 CD I-NP O
( -LRB- I-NP O
6.0-8.3 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Albumin NNP B-NP O
4.1 CD I-NP O
( -LRB- O O
3.3-5.0) CD B-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
3.5 CD I-NP O
( -LRB- I-NP O
2.6-4.1 CD B-NP O
) -RRB- I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.1 CD I-NP O
(0-0.4 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.2 CD I-NP O
(0-1.0) JJ I-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
90 CD I-NP O
( -LRB- I-NP O
30-100 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGPT NNP B-NP O
18 CD I-NP O
(7-30 CD I-NP O
) -RRB- I-NP O
U/L . O O
Creatine NNP B-NP O
Kinase NNP I-NP O
Isoenz NNP I-NP O
2.5 CD I-NP O
( -LRB- I-NP O
0.0-6.9 CD I-NP O
) -RRB- I-NP O
ng/ml . O O
CPK NNP B-NP O
Isoenzymes NNP I-NP O
Index NNP I-NP O
( -LRB- B-VP O
0.0-3.5 CD B-PP O
) -RRB- B-NP O
% NN I-NP O
CPK NNP B-NP O
and/or CC I-NP O
CKMB NNP I-NP O
too RB I-NP O
low JJ B-ADJP O
to TO B-VP O
calculate VB I-VP O
Relative NNP B-NP O
Index NNP I-NP O
. . O O
Troponin-T NNP B-NP O
<0.01 CD I-NP O
( -LRB- I-NP O
0.00-0.09 CD I-NP O
) -RRB- I-NP O
ng/ml . O O
Transaminase-SGOT NNP B-NP O
25 CD I-NP O
( -LRB- I-NP O
9-32 CD I-NP O
) -RRB- I-NP O
U/L . O O
Creatine NNP B-NP O
Kinase NNP I-NP O
66 CD I-NP O
( -LRB- I-NP O
40-150 CD I-NP O
) -RRB- I-NP O
U/L . O O
12-Dec-2091 CD B-NP B-DATE
18:22 CD I-NP O
Accession NNP B-NP O
# # I-NP O
4334L01518 CD O B-MEDICALRECORD
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Creatine NNP B-NP O
Kinase NNP I-NP O
Isoenz NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
Troponin-I JJ B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
12-Dec-2091 CC O B-DATE
17 CD B-NP O
:51 CD I-NP O
Accession NNP B-NP O
# # I-NP O
7758U11191 CD O B-MEDICALRECORD
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Amylase NNP B-NP O
136 CD I-NP O
H NNP B-NP O
(3-100 CD I-NP O
) -RRB- O O
units/L NN O O
Lipase NNP B-NP O
8.3 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
1.3-6.0) CD I-NP O
U/dl NN I-NP O
Radiology NNP B-NP O
: : O O
Dissection NNP B-NP O
Protocol NNP I-NP O
CT NNP I-NP O
of IN B-PP O
12-Dec-2091 CD B-NP B-DATE
: : O O
reveals VBZ B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
aortic JJ B-NP O
dissection NN I-NP O
. . O O
Complex NNP B-NP O
cyst NN I-NP O
within IN B-PP O
the DT B-NP O
spleen JJ I-NP O
. . I-NP O
Uterine NNP I-NP O
fibroids NNS I-NP O
. . O O
Degenerative NN B-VP O
disc NN B-NP O
disease NN I-NP O
. . O O
CXR NN B-NP O
of IN B-PP O
12-Dec-2091 CD B-NP B-DATE
: : O O
The DT B-NP O
lungs NNS I-NP O
are VBP B-VP O
clear JJ B-ADJP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
pneumothorax NN B-NP O
. . O O
The DT B-NP O
heart NN I-NP O
size NN I-NP O
is VBZ B-VP O
normal JJ B-ADJP O
. . O O
The DT B-NP O
bones NNS I-NP O
are VBP B-VP O
unremarkable JJ B-ADJP O
. . O O
EKG NNP B-NP O
: : O O
12-Dec-2091 CD B-NP B-DATE
: : O O
Sinus NNP B-NP O
brady NN I-NP O
with IN B-PP O
a DT B-NP O
rate NN I-NP O
of IN B-PP O
approximately RB B-NP O
50 CD I-NP O
. . O O
Normal JJ B-NP O
axis NN I-NP O
. . O O
Normal JJ B-NP O
intervals NNS I-NP O
. . O O
No DT B-NP O
ST NNP I-NP O
elevations NNS I-NP O
or CC I-NP O
depressions NNS I-NP O
. . O O
Q NN B-NP O
waves NNS I-NP O
in IN B-PP O
leads NNS B-NP O
II NNP I-NP O
, , I-NP O
III NNP I-NP O
and CC I-NP O
AVF NNP I-NP O
c/w RB I-NP O
prior RB I-NP O
inferior JJ I-NP O
infarct NN I-NP O
. . O O
Q NN B-NP O
waves NNS I-NP O
in IN B-PP O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
. . I-NP O
Good NNP I-NP O
R NN I-NP O
wave NN I-NP O
progression NN I-NP O
. . O O
No DT B-NP O
atrial NN I-NP O
or CC I-NP O
ventricular JJ I-NP O
enlargement NN I-NP O
noted VBD B-VP O
. . O O
No DT B-NP O
change NN I-NP O
from IN B-PP O
prior JJ B-NP O
EC NNP I-NP O
G NNP I-NP O
's POS B-NP O
. . O O
Adenosine NNP B-NP O
MIBI NNP I-NP O
6/20/2089 CD I-NP B-DATE
: : O O
The DT B-NP O
ECG JJ I-NP O
response NN I-NP O
to TO B-PP O
pharmacological JJ B-NP O
stress NN I-NP O
was VBD B-VP O
negative JJ B-ADJP O
for IN B-PP O
ischemia NN B-NP O
. . O O
The DT B-NP O
myocardial JJ I-NP O
perfusion NN I-NP O
scans NNS I-NP O
show VBP B-VP O
a DT B-NP O
small JJ I-NP O
size NN I-NP O
, , O O
mild JJ O O
intensity NN B-NP O
, , O O
primarily RB B-ADVP O
fixed VBN B-VP O
inferolateral NN B-NP O
defect NN I-NP O
consistent JJ B-ADJP O
with IN B-PP O
prior JJ B-NP O
infarct NN I-NP O
with IN B-PP O
substantial JJ B-NP O
residual JJ I-NP O
viable JJ I-NP O
myocardium NN I-NP O
but CC O O
only RB O O
minimal JJ B-NP O
stress NN I-NP O
induced VBN I-NP O
ischemia NN I-NP O
. . O O
Compared VBN B-VP O
to TO B-PP O
the DT B-NP O
study NN I-NP O
of IN B-PP O
01/26 CD B-NP B-DATE
with IN B-PP O
treadmill NN B-NP O
exercise NN I-NP O
( -LRB- I-NP O
RPP NNP I-NP O
~24K) IN B-PP O
the DT B-NP O
previously RB I-NP O
noted JJ I-NP O
anterior JJ I-NP O
wall NN I-NP O
defect NN B-NP O
is VBZ B-VP O
less RBR B-ADJP O
apparent JJ I-ADJP O
in IN B-PP O
the DT B-NP O
present JJ I-NP O
exam NN I-NP O
. . O O
CARDIAC NNP B-NP O
CATH NNP I-NP O
OF IN B-PP O
12/09/2082 CD B-NP B-DATE
: : O O
Successful JJ B-NP O
PTCA NNP I-NP O
of IN B-PP O
the DT B-NP O
mid JJ I-NP O
RCA NN I-NP O
with IN B-PP O
a DT B-NP O
3.0 CD I-NP O
mm CD I-NP O
balloon NN I-NP O
with IN B-PP O
20 CD B-NP O
to TO B-PP O
30 CD B-NP O
per IN B-PP O
cent NN B-NP O
residual NN I-NP O
plaque NN I-NP O
and CC O O
a DT B-NP O
hazzines VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
possible JJ B-NP O
small JJ I-NP O
dissection NN I-NP O
. . O O
Pt NNP B-NP O
referred VBD B-VP O
by IN B-PP O
Dr. NNP B-NP O
YARBROUGH NNP I-NP B-DOCTOR
, , O O
underwent JJ B-NP O
catheterization NN I-NP O
for IN B-PP O
unstable JJ B-NP O
angina NN I-NP O
, , O O
a DT B-NP O
positive JJ I-NP O
exercise NN I-NP O
text NN I-NP O
and CC O O
recent JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
. . O O
PROCEDURE NN B-NP O
PERCUTANEOUS NNP B-NP O
TRANSLUMINAL NNP I-NP O
CORONARY NNP I-NP O
ANGIOPLASTY NNP I-NP O
was VBD B-VP O
performed VBN I-VP O
on IN B-PP O
the DT B-NP O
Mid NNP I-NP O
RCA NNP I-NP O
using VBG B-VP O
a DT B-NP O
maximum JJ I-NP O
balloon NN I-NP O
size NN I-NP O
of IN B-PP O
3.0 CD B-NP O
mm CD I-NP O
advanced VBN B-VP O
through IN B-PP O
a DT B-NP O
9YS7EZ JJ I-NP B-DEVICE
guiding VBG I-NP O
catheter NN I-NP O
. . O O
Assessment NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
a DT B-NP O
59 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
female NN I-NP O
with IN B-PP O
h/o NN B-NP O
SLE NNP I-NP O
, , I-NP O
interstitial JJ I-NP O
nephritis NN I-NP O
, , O O
GERD NNP B-NP O
, , O O
h/o RB B-NP O
positive JJ I-NP O
stress NN I-NP O
s/p VBD B-VP O
RCA NNP B-NP O
angioplasty JJ I-NP O
2082 CD I-NP B-DATE
, , O O
and CC O O
chronic NN B-NP O
abdominal JJ I-NP O
pain NN I-NP O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
c/o JJ B-NP O
two CD I-NP O
weeks NNS I-NP O
of IN B-PP O
intermittent NN B-NP O
chest NN I-NP O
pain NN I-NP O
reproducible VBN B-VP O
upon IN B-PP O
palpation NN B-NP O
who WP B-NP O
is VBZ B-VP O
admitted VBN I-VP O
to TO I-VP O
rule VB I-VP O
out RP B-PRT O
MI NNP B-NP O
with IN B-PP O
one CD B-NP O
set NN I-NP O
of IN B-PP O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
and CC O O
no DT B-NP O
EKG JJ I-NP O
changes NNS I-NP O
. . O O
Plan NNP B-NP O
: : O O
1 CD B-NP O
. . O O
Chest NNP B-NP O
Pain NNP I-NP O
: : O O
Likely RB B-NP O
musculoskeletal NN I-NP O
in IN B-PP O
nature NN B-NP O
given VBN I-NP O
reproducibility NN I-NP O
of IN B-PP O
pain NN B-NP O
on IN B-PP O
palpation NN B-NP O
. . O O
However RB B-ADVP O
, , O O
given VBN B-NP O
pt NN I-NP O
's POS B-NP O
cardiac JJ I-NP O
history NN I-NP O
, , O O
will MD B-VP O
obtain VB I-VP O
two CD B-NP O
more JJR I-NP O
sets NNS I-NP O
of IN B-PP O
cardiac JJ B-NP O
markers NNS I-NP O
. . O O
Adenosine NN B-VP O
stress NN B-NP O
test NN I-NP O
scheduled VBN B-VP O
for IN B-PP O
a.m. RB B-NP O
with IN B-PP O
echocardiogram NN B-NP O
pending VBG I-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
. . O O
Pt NNP B-NP O
's POS B-NP O
Atenenlol NNP I-NP O
switched VBD B-VP O
to TO B-PP O
Lopressor NNP B-NP O
during IN B-PP O
admission NN B-NP O
. . O O
Pt NNP B-NP O
Dilatrate-SR NNP I-NP O
changed VBD B-VP O
to TO B-PP O
Isordil NNP B-NP O
. . I-NP O
Continuing NNP I-NP O
home NN I-NP O
meds NNS I-NP O
of IN B-PP O
Nifedipine NNP B-NP O
and CC I-NP O
ASA NNP I-NP O
. . O O
Pt NNP O O
to TO B-VP O
be VB I-VP O
NPO NNP B-NP O
after IN B-PP O
midnight NN B-NP O
for IN B-PP O
am RB B-NP O
cardiac JJ I-NP O
testing NN I-NP O
. . O O
2. DT B-NP O
SLE NNP I-NP O
: : O O
Continuing VBG B-VP O
home NN B-NP O
dose NN I-NP O
of IN B-PP O
prednisone NN B-NP O
, , O O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
Vitamins NNP B-NP O
C NNP I-NP O
and CC O O
D. NNP B-NP O
Will MD B-VP O
notify VB I-VP O
Dr. NNP B-NP O
Xie NNP I-NP B-DOCTOR
that IN B-PP O
pt NN B-NP O
is VBZ B-VP O
in-house RB B-ADVP O
per IN B-PP O
request NN B-NP O
of IN B-PP O
PCP NNP B-NP O
, , O O
to TO B-VP O
determine VB I-VP O
if IN B-PP O
any DT B-NP O
further JJ I-NP O
Rheum NNP I-NP O
w/u NN I-NP O
is VBZ B-VP O
necessary JJ B-ADJP O
. . O O
3. DT B-NP O
GI NNP I-NP O
: : O O
Will MD B-VP O
repeat VB I-VP O
amylase NN B-NP O
and CC I-NP O
lipase NN I-NP O
. . O O
Prednisone NN B-NP O
is VBZ B-VP O
a DT B-NP O
known JJ I-NP O
cause NN I-NP O
of IN B-PP O
pancreatitis NN B-NP O
and CC I-NP O
pt NN I-NP O
's POS B-NP O
continued VBN I-NP O
abdominal NN I-NP O
complaints NNS I-NP O
may MD B-VP O
be VB I-VP O
pancreatic JJ B-ADJP O
in IN B-PP O
origin NN B-NP O
. . O O
although IN O O
unlikely JJ B-ADJP O
as IN B-SBAR O
elevation NN B-NP O
is VBZ B-VP O
minimal JJ B-ADJP O
. . O O
Olivia NNP B-NP B-DOCTOR
H. NNP I-NP I-DOCTOR
Grant NNP I-NP I-DOCTOR
pager NN B-NP O
00933 CD I-NP B-PHONE
